MONTREAL, QUEBEC--(Marketwire - May 16, 2008) - MethylGene Inc. (TSX: MYG) today announced that data from MGCD0103 clinical trials will be presented in one oral and two poster presentations at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting which will be held from May 30 to June 3, 2008 in Chicago, Illinois.
